Editor's note: This article has been updated with a quote from iCardio.ai CEO.
Los Angeles-based iCardio.ai has received FDA 510(k) clearance for its artificial intelligence software for interpretation of echocardiography, aimed at offering a comprehensive imaging workflow and autonomous preliminary reporting.
iCardio.ai develops machine learning and deep learning algorithms for the examination...
An international study led by researchers at the Faculty of Dentistry of the University of Hong Kong has developed and tested a new AI model for screening gingivitis, or gum inflammation, from images inside the mouth.
FINDINGS
The study, which is one of the first to explore the use of AI in spotting gingivitis, made use of 550 gum images with varying degrees of inflammation.
Based on findings,...
Medical AI startup Qritive has pooled $7.5 million in a funding round led by MassMutual Ventures and supported by Enterprise Singapore's investment arm SEEDS Capital and Exfinity Venture Partners.
WHAT IT DOES
Founded in 2017, the Singapore-headquartered company offers diagnostic support solutions that provide fast and accurate pathological interpretations "within seconds." Its digital pathology...
South Korean medical AI company Coreline Soft has obtained medical device certifications from Singapore's Health Sciences Authority for its line of AI diagnostic support solutions.
Founded in 2012, the company develops AI imaging diagnosis solutions, specialising in thoracic disorders.
It gained approvals from Singapore's HSA for the following nine software solutions:
AVIEW LCS, an AI-based...
Artrya secures UK, EU approvals for Salix
Within a week, ASX-listed medtech company Artrya received both regulatory approvals from the European Union and the United Kingdom for its Salix Coronary Anatomy product.
The AI-powered software identifies and analyses arterial plaque to diagnose coronary artery disease.
The recent certifications allow Artrya to market Salix in 28 EU member countries and...
The Industrial Technology Research Institute, a non-profit R&D organisation in Taiwan, has unveiled its AI-assisted system for detecting diabetic eye diseases.
WHAT IT'S ABOUT
Point-of-care AI-DR can instantly diagnose diabetic retinopathy and diabetic eye oedema in five to 10 seconds. It can locate from fundus images four main lesions – microaneurysms, haemorrhages, soft exudates, and hard...
Karkinos Healthcare, a technology-driven cancer care platform in India, has entered into a strategic partnership with American oncology diagnostics firm C2i Genomics to promote AI-enabled cancer monitoring in the country.
According to a press statement, their partnership will expand minimal residual disease (MRD) monitoring across Karkinos' network using C2i Genomics' whole-genome analysis...
Healthcare AI firm annalise.ai has partnered with Fujifilm Australia for the distribution of its decision support solutions for portable and stationary chest x-ray machines.
Annalise CXR Edge is a software as a medical device that assists clinicians and radiologists in interpreting chest x-rays. According to the company, its AI algorithm identifies and notifies suspected findings in under 10...
New Zealand-based AI healthcare firm Toku Eyes has brought its retina-based AI health screening platform to the United States.
Its latest offering, the ORAiCLE, can assess and calculate a person's cardiovascular risk through a retinal scan. Still pending a patent, the AI technology uses an image of the back of a user's eye taken from a retinal camera. The platform spots minute changes in blood...
Fujitsu has teamed up with Southern Tohoku General Hospital in Fukushima, Japan for a joint research project to come up with an AI solution that detects pancreatic cancer from CT scans at an early stage.
According to a press release, the project will use Fujitsu's AI tech, which has been trained with over 300 anonymised CT images of pancreatic cancer patients at Southern Tohoku General Hospital,...
